switching glp 1 agonists Between Glucagon-Like Peptide-1 Receptor Agonists: Rationale and Practical Guidance Compare GLP-1 Options | Ozempic
Description
TT-OAD2 is another small molecule that also exhibits biased agonism in a unique binding mode [46]
AP events were predominantly reported for unknown indications (53.8%) and T2DM (43.0%)
[DOI] [PMC free article] [PubMed] [Google Scholar] 67.American Diabetes Association Professional Practice Committee 14
17 Similarly, in a meta-analysis of 14 RCTs in T2DM patients conducted by Liu et al, tirzepatide was shown to provide superior HbA1c reduction and improved metabolic outcomes compared to placebo, insulin, and all other GLP-1 RAs at all doses examined
doi:10.1002/dmrr.2723 146
